OVERVIEW
Epilepsy is a condition characterized by recurrent seizures that strike without warning. Symptoms may range from brief suspension of awareness, to loss of consciousness, to violent convulsions. For people that fail to have their seizures controlled with medications these seizures can have a devastating impact on quality of life.
For many people with uncontrolled seizures, these episodic events are relatively infrequent and brief. In fact, for most, the cumulative time spent in seizure is less than one hour per year, yet there is not a moment where these people feel safe. While the symptoms of epilepsy are episodic and typically of short duration, it is often the constant fear and uncertainty as to when the next seizure is going to strike that make it chronically debilitating.
NeuroVista is working to identify physiological signals that may make it possible to forewarn a person when a seizure is likely to occur. Highly sophisticated techniques in signal processing, machine learning, and time-series analysis are at the core of the Company’s research and development. The Company has assembled one of the world’s largest databases of intracranial Electrocorticography (ECoG) recordings and developed vast computational resources to assist in the identification and analysis of signals that may enable practical seizure advisory.
Resolving the uncertainty of seizure occurrence for people with epilepsy may significantly improve quality of life by reducing anxiety and helplessness, restoring a sense of control, reducing physical injuries and enabling many activities of daily living.